About PanTher Therapeutics
PanTher Therapeutics is a private company based in Austin, Texas. It has reported $15,962,260 raised in nine offerings on Form D since June 2015. Its chief executive is Laura Indolfi.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 14, 2025 | Apr 3, 2025 | $3,021,707of $5.0M target | 26 | $116K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 30, 2023 | Dec 18, 2023 | $2,676,030of $5.0M target | 28 | $95,573 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 5, 2022 | Dec 19, 2022 | $1,261,500of $2.0M target | 15 | $84,100 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 1, 2022 | Jun 24, 2022 | $1,061,000of $1.2M target | 17 | $62,412 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| May 27, 2020 | Jun 4, 2020amended Jun 2, 2021 | $7,334,474fully sold | 59 | $124K | Equity, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 10, 2019 | May 18, 2020 | $209,488fully sold | 15 | $13,966 | DebtRule 506(b) | Form D ↗ |
| Aug 7, 2018 | May 14, 2020 | $268,061fully sold | 6 | $44,677 | DebtRule 506(b) | Form D ↗ |
| Oct 28, 2016 | Nov 10, 2016 | $35,000of $500K target | 1 | $35,000 | DebtRule 506(b) | Form D ↗ |
| Jun 1, 2015 | Jun 8, 2015 | $95,000of $500K target | 3 | $31,667 | DebtRule 506(b) | Form D ↗ |
| Total, nine offerings | $15,962,260 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PanTher Therapeutics's Form D filed Apr 3, 2025.
LI
Laura Indolfi
Chief Executive Officer and director
DM
D Mackey
Director
DW
Daniel Wildman
Director
DZ
MP
Maria Palasis
Director
Earlier filings also listed Manish Bhandari (director, last listed Dec 2023), John Edwards (director, last listed Dec 2023), David Ting (director, last listed Dec 2022) and Elazer Edelman (director, last listed May 2020).